razoxane has been researched along with Local Neoplasm Recurrence in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (50.00) | 18.7374 |
| 1990's | 3 (25.00) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chintagumpala, M; Davino, N; Helman, L; Hicks, J; Johnson, M; Lau, CC; Man, TK; Meyer, W; Murray, J; Perlaky, L; Shen, J; Triche, T; Visvanathan, J; Wong, KK | 1 |
| Eiter, H; Hammer, J; Rhomberg, W; Schneider, B; Sedlmayer, F; Seewald, D | 1 |
| Blessing, JA; Conroy, JF; Homesley, HD; Kessinger, A | 1 |
| Arsenau, JC; Blessing, J; Lewis, GC; Slavik, M | 1 |
| Cassell, PG; Ellis, H; Evans, M; Gilbert, JM; Hellmann, K; Stoodley, B; Wastell, C | 1 |
| Baker, D; Constable, W; Elkon, D; Rinehart, L | 1 |
| Eiter, H; Hergan, K; Rhomberg, W; Schneider, B | 1 |
| Grass, M; Rhomberg, W | 1 |
| Alton, R; Beer, G; Breitfellner, G; Jasarevic, Z; Kompatscher, P; Rhomberg, W | 1 |
| Eiter, H; Rhomberg, W | 2 |
| Cassell, PG; Ellis, H; Evans, M; Gilbert, JM; Hellmann, K; Stoodley, B; Taylor, RH; Wastell, C | 1 |
2 review(s) available for razoxane and Local Neoplasm Recurrence
| Article | Year |
|---|---|
[Angiosarcoma of the right atrium: local control via low radiation doses and razoxane. A case report].
Topics: Aged; Antineoplastic Agents; Chemotherapy, Adjuvant; Fatal Outcome; Heart Atria; Heart Neoplasms; Hemangiosarcoma; Humans; Liver Neoplasms; Lung Neoplasms; Male; Neoplasm Recurrence, Local; Radiotherapy Dosage; Radiotherapy, Adjuvant; Razoxane | 1999 |
[Radio-oncological treatment possibilities in local recurrence of rectal carcinoma. An interdisciplinary comparison].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Humans; Neoplasm Recurrence, Local; Piperazines; Radiation-Sensitizing Agents; Radiotherapy Dosage; Razoxane; Rectal Neoplasms; Survival Analysis | 1990 |
4 trial(s) available for razoxane and Local Neoplasm Recurrence
| Article | Year |
|---|---|
Irradiation with and without razoxane in the treatment of incompletely resected or inoperable recurrent rectal cancer. Results of a small randomized multicenter study.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Austria; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Radiotherapy, Adjuvant; Razoxane; Rectal Neoplasms; Treatment Outcome | 2007 |
Adjuvant oral razoxane (ICRF-159) in resectable colorectal cancer.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Colonic Neoplasms; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Piperazines; Razoxane; Rectal Neoplasms | 1982 |
Inoperable recurrent rectal cancer: results of a prospective trial with radiation therapy and razoxane.
Topics: Adult; Aged; Aged, 80 and over; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Palliative Care; Prospective Studies; Radiation-Sensitizing Agents; Radiotherapy; Razoxane; Rectal Neoplasms; Survival Rate | 1994 |
Randomized trial of oral adjuvant razoxane (ICRF 159) in resectable colorectal cancer: five-year follow-up.
Topics: Clinical Trials as Topic; Colonic Neoplasms; Follow-Up Studies; Humans; Neoplasm Recurrence, Local; Piperazines; Prospective Studies; Random Allocation; Razoxane; Rectal Neoplasms | 1986 |
6 other study(ies) available for razoxane and Local Neoplasm Recurrence
| Article | Year |
|---|---|
Expression profiles of osteosarcoma that can predict response to chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Neoplasms; Child; Cisplatin; Combined Modality Therapy; Doxorubicin; Drug Resistance, Neoplasm; Female; Gene Expression Profiling; Humans; Male; Methotrexate; Neoplasm Recurrence, Local; Nuclear Proteins; Osteosarcoma; Predictive Value of Tests; Prognosis; Razoxane; Reverse Transcriptase Polymerase Chain Reaction; Survival Rate; Twist-Related Protein 1 | 2005 |
Phase II trial of razoxane in the management of recurrent adenocarcinoma of the ovary: a Gynecologic Oncology Group study.
Topics: Adenocarcinoma; Adult; Aged; Drug Evaluation; Female; Humans; Leukopenia; Middle Aged; Nausea; Neoplasm Recurrence, Local; Ovarian Neoplasms; Piperazines; Razoxane; Thrombocytopenia | 1984 |
Phase II studies in advanced, recurrent pelvic malignancies: conducted by the Gynecologic Oncology Group, Experimental Design and Experience.
Topics: Adenocarcinoma; Antineoplastic Agents; Carcinoma, Squamous Cell; Cisplatin; Dianhydrogalactitol; Drug Evaluation; Etoposide; Female; Humans; Maytansine; Neoplasm Recurrence, Local; Pelvic Neoplasms; Piperazines; Razoxane; Research Design; Triazines | 1982 |
The influence of ICRF-159 and levamisole on the incidence of metastases following local irradiation of a solid tumor.
Topics: Animals; Female; Levamisole; Mice; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms; Neoplasms, Radiation-Induced; Piperazines; Radiotherapy; Radiotherapy Dosage; Razoxane; Risk | 1981 |
Aggressive angiomyxoma: irradiation for recurrent disease.
Topics: Adult; Diagnosis, Differential; Humans; Male; Myxoma; Neoplasm Recurrence, Local; Palliative Care; Radiation-Sensitizing Agents; Razoxane | 2000 |
[Radiation sensitivity studies of inoperable and recurrent rectal carcinomas].
Topics: Brachytherapy; Cesium Radioisotopes; Cobalt Radioisotopes; Combined Modality Therapy; Humans; Neoplasm Recurrence, Local; Palliative Care; Prospective Studies; Radiation Injuries; Radiation Tolerance; Radiation-Sensitizing Agents; Radioisotope Teletherapy; Radiotherapy Dosage; Razoxane; Rectal Neoplasms; Remission Induction | 1989 |